Envestnet Portfolio Solutions Inc. Cuts Stake in Johnson & Johnson Amid Strong Earnings

Envestnet Portfolio Solutions Inc., a financial services company, recently reduced its stake in Johnson & Johnson (JNJ) by selling 6,962 shares during the second quarter. The firm's holdings in JNJ now stand at 71,666 shares, valued at approximately $18.19 million.

This move is part of Envestnet Portfolio Solutions Inc.'s larger strategy to adjust its investment portfolio. As a hedge fund and institutional investor, it has been making adjustments to its holdings throughout the year.

Johnson & Johnson, one of the largest pharmaceutical companies in the world, reported strong earnings results for the second quarter, exceeding analysts' expectations. The company's revenue grew by 6.6% year-over-year, with net income increasing by 7.5%. The stock has been performing well, with a price-to-earnings ratio of 30.18 and a beta of 0.24.

Other notable investors have also made significant changes to their holdings in JNJ recently. Vanguard Group Inc., for instance, increased its stake by 1.6% during the fourth quarter, while State Street Corp raised its position by 1.3%. Auto Owners Insurance Co lifted its investment by an astonishing 22,225.6%.